Moreover, cellular colocalization and ITCmeasurements of the compound with the protein (Figure 3B,C) confirmed the formation of the NPM1-UCM-13369complex, validating the NPM1 protein as a molecular target of thenew small-molecule targeting AML. This evidence concerns the gene NPM1 and acute myeloid leukemia.